Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Libing Fu
Novel SMARCA4 :: VEZF1 Rearrangement in Pediatric Sarcomas
Libing Fu, Rongjun Mao, and Changliang Zhang contributed equally to this work. L.Fu, R.Mao, C.Zhang, et al., “Novel SMARCA4::VEZF1 Rearrangement in Pediatric Sarcomas,” Genes, Chromosomes and Cancer65, no. 5 (2026): e70132, https://doi.org/10.1002/gcc.70132. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available on request from the corresponding author.
Mosaic DICER1 RNase IIIb hotspot mutation with multiple tumors: case report and literature review
Abstract We present a case of a 6-month-old boy who was diagnosed with Peutz–Jeghers polyps, intestine fusiform mesenchymal tumor, Wilms tumor, and Ir type pleuropulmonary blastoma (PPB) successively, with mosaic DICER1 RNase IIIb hotspot mutation: c.5113G>A p.E1705K. The patient underwent surgeries to resect the intestine polyps, intestine tumor, Wilms tumor, nephroblastomatosis, and PPB, combined with chemotherapy aimed at Wilms tumor and PPB.
Energies | Free Full-Text | Improve Oil Recovery Mechanism of Multi-Layer Cyclic Alternate Injection and Production for Mature Oilfield at Extra-High Water Cut Stage Using Visual Physical Simulation Experiment
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Lun Zhao 1, Jincai Wang 1, Libing Fu 1,*, Li Chen 1 and Zhihao Jia 2 1 PetroChina Research Institute of Petroleum Exploration & Development, Beijing 100083, China 2 College of Petroleum Engineering, China University of Petroleum (Beijing), Beijing 100083, China * Author to whom correspondence should be addressed.
J | Free Full-Text | Reducing the Immunogenicity of Pulchellin A-Chain, Ribosome-Inactivating Protein Type 2, by Computational Protein Engineering for Potential New Immunotoxins
3. Results and Discussion Exploiting plants to synthesize toxins like pulchellin, might promote the production of recombinant immunotoxins (antibody–toxin fusion proteins) [43]. The use of toxic enzymes to make ITs is a vital field. The main limits to the clinical use of heterologous proteins derive from their immunogenicity and, to a lesser extent, from their systemic toxicity.
Published by AME Publishing Company Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China. Email: pm@amegroups.com
Clinical and Histopathological Features of Congenital Fibrovascular Pupillary Membranes in a Chinese Case Series
Original Article Abstract Purpose: To investigate the clinical and histopathological features of congenital fibrovascular pupillary membrane (CFPM) in Chinese patients. Methods: This retrospective study reviewed CFPM cases treated at Beijing Children's Hospital. The clinical manifestations, approaches of treatment, outcomes, and histopathological findings were collected and analyzed. Results: A total of 33 patients with CFPM were reviewed. All patients had unilateral eye involvement.
Extrarenal Wilms tumor in children: a retrospective observational case series
Summary Introduction Pediatric extrarenal Wilms tumor (ERWT) is rare. The diversity of clinical characteristics makes diagnosis, treatment and judging the prognosis difficult. Long-term follow-up outcomes and the possible prognostic factors of ERWT are still insufficient. Objective To identify the characteristics, therapeutic strategies and long-term results of pediatric ERWT. Patients and Methods All children with ERWT in our institution were retrospectively reviewed.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Libing
Contact Libing, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack